[HTML] springer.comFull View

[HTML][HTML] A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do, N Kim, YJ Ju… - Alzheimer's research & …, 2020 - Springer
Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …
被引用次数：78 相关文章

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do… - … research & therapy, 2020 - pubmed.ncbi.nlm.nih.gov
Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …
[HTML] biomedcentral.com

[HTML][HTML] A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do… - Alzheimer's …, 2020 - alzres.biomedcentral.com
Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal cell loss,
and cognitive impairment are pathological presentations of Alzheimer's disease (AD) …

[引用][C] A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, N Kim, YJ Ju… - … Research & Therapy …, 2020 - jglobal.jst.go.jp
A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and
modulates microglia function in 5XFAD mouse | Article Information | J-GLOBAL Art J-GLOBAL …
[PDF] archive.org

[PDF][PDF] A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do, N Kim, YJ Ju, SJ Lee… - 2020 - scholar.archive.org
Background: Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.

MS Gee, SH Son, SH Jeon, J Do… - Alzheimer's …, 2020 - search.ebscohost.com
Background: Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …
[HTML] nih.gov

[HTML][HTML] A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do, N Kim… - … Research & Therapy, 2020 - ncbi.nlm.nih.gov
Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.

MS Gee, SH Son, SH Jeon, J Do, N Kim… - … Research & Therapy, 2020 - europepmc.org
Background Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …

A selective p38α/β MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse

MS Gee, SH Son, SH Jeon, J Do… - Alzheimer's …, 2020 - khu.elsevierpure.com
Background: Chronic neuroinflammation, aggressive amyloid beta (Aβ) deposition, neuronal
cell loss, and cognitive impairment are pathological presentations of Alzheimer's disease …

A selective p38 [alpha]/[beta] MAPK inhibitor alleviates neuropathology and cognitive impairment, and modulates microglia function in 5XFAD mouse.

MS Gee, SH Son, SH Jeon, J Do, N Kim… - … Research & Therapy, 2020 - go.gale.com
Background Chronic neuroinflammation, aggressive amyloid beta (A [beta]) deposition,
neuronal cell loss, and cognitive impairment are pathological presentations of Alzheimer's …